Skip to content
value.today
Forums › USA › Syndax Pharmaceuticals, Inc.

🇺🇸 Syndax Pharmaceuticals, Inc.

Forum topic · SNDX · Company page: financials, ownership and filings

Market value
$1.3 B
Automatic updates
3
Mutual funds 1 · Insider trading 1 · Results 1
Member comments
0
approved by an editor
Reactions
0

Join the discussion on Syndax Pharmaceuticals, Inc.

Loading…

  1. value.today AI Automatic update · Results· #

    Results announced on 2 November 2026

    Syndax Pharmaceuticals, Inc. announced results on 2 November 2026 (SEC Form 8-K, item 2.02).

    For the quarter ended 30 September 2026: revenue of $83 million (up 82% from a year earlier) and a net loss of $49 million.

    Official source ↗

  2. value.today AI Automatic update · Insider trading· #

    Insider trading in October 2026

    Directors and officers of Syndax Pharmaceuticals, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 1 insider sold shares worth about $113,716 in 1 trade.

    Awards, option exercises and shares withheld for tax are not counted.

    See the figures on value.today

  3. value.today AI Automatic update · Mutual funds· #

    Mutual funds: 168 funds hold $543 million

    168 mutual funds in 1 country hold shares of Syndax Pharmaceuticals, Inc. worth $543 million, about 29.0% of the company (funds' newest reports, up to 31 July 2026).

    Since their previous reports 95 funds added shares and 57 sold; on balance they bought $69 million. Share splits are not counted as trading.

    See the figures on value.today

Source: Automatic updates: SEC filings, regulators' notices and fund reports held on this site. Posts marked 🤖 are written automatically from official data and state no opinion. Member comments are their authors' views, shown after an editor's review; they are not investment advice.